Kynam Capital Management, LP Beam Therapeutics Inc. Transaction History
Kynam Capital Management, LP
- $1.18 Billion
- Q3 2025
A detailed history of Kynam Capital Management, LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 2,517,647 shares of BEAM stock, worth $55.4 Million. This represents 5.16% of its overall portfolio holdings.
Number of Shares
2,517,647
Previous 2,417,647
4.14%
Holding current value
$55.4 Million
Previous $41.1 Million
48.58%
% of portfolio
5.16%
Previous 4.91%
Shares
5 transactions
Others Institutions Holding BEAM
# of Institutions
251Shares Held
95MCall Options Held
910KPut Options Held
583K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$243 Million1.88% of portfolio
-
Farallon Capital Management LLC San Francisco, CA10.1MShares$222 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.25MShares$204 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$168 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.4.83MShares$106 Million1.27% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.55B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...